IO Biotech Inc (IOBT) — Cash Flow-to-Debt Ratio
Latest as of September 2025:
-0.47x
IO Biotech Inc (IOBT) has a Cash Flow-to-Debt Ratio of -0.47x as of September 2025, meaning its operating cash flow of $-18.48 Million could theoretically repay 0% of its total liabilities ($39.05 Million) in one year. Explore IOBT cash flow conversion to assess how effectively this company generates cash.
CF-to-Debt Ratio
-0.47x
Operating CF / Total Liabilities
Operating Cash Flow
$-18.48 Million
USD
Total Liabilities
$39.05 Million
USD
Data as of
Sep 2025
Most recent filing
IO Biotech Inc Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for IO Biotech Inc across 6 annual periods. Also explore total assets of IO Biotech Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for IO Biotech Inc (2019–2024)
Year-by-year debt coverage analysis for IO Biotech Inc. For market capitalisation and broader financial context, see IO Biotech Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.98x | $-82.35 Million | $20.68 Million | ▲ +2.6% |
| 2023 | -4.09x | $-71.74 Million | $17.56 Million | ▲ +11.4% |
| 2022 | -4.61x | $-59.73 Million | $12.95 Million | ▼ -17.6% |
| 2021 | -3.92x | $-40.65 Million | $10.36 Million | ▼ -20.1% |
| 2020 | -3.26x | $-9.96 Million | $3.05 Million | ▼ -300.0% |
| 2019 | -0.82x | $-8.89 Million | $10.89 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.